Loratadine. A review of recent findings in pharmacology, pharmacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine.

作者: I J Roman , M R Danzig

DOI: 10.1007/BF02802295

关键词: PseudoephedrineDosingHistamine H1 receptorAnticholinergicLoratadineAllergyMedicinePharmacotherapyPharmacologyTherapeutic effect

摘要: Antihistamines are considered first-line therapy for the relief of symptoms from allergic rhinitis and chronic urticaria. The newer, second-generation, nonsedating antihistamines reduce central nervous system anticholinergic side effects commonly found with previous drugs. availability H1-receptor antagonists that produce therapeutic without causing unwanted CNS fulfills an important practical need, since these drugs clearly preferable in patients who drive or operate heavy machinery, involved activities requiring full alertness. Physicians alike pleased efficacy safety second-generation bring to treatment allergy symptoms. Loratadine is especially effective antagonist comparable many other antihistamines. may be particularly advantageous because its low dose convenience once-daily dosing. A more subtle advantage, loratadine's antiallergic properties, warrant use specific situations as future research clarifies nature inflammatory response mechanisms action have this regard.

参考文章(29)
A. W. K. Gaillard, A. Gruisen, R. de Jong, The influence of antihistamines on human performance. European Journal of Clinical Pharmacology. ,vol. 35, pp. 249- 253 ,(1988) , 10.1007/BF00558261
G BRUTTMANN, D CHARPIN, J GERMOUTY, F HORAK, G KUNKEL, G WITTMANN, Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis. The Journal of Allergy and Clinical Immunology. ,vol. 83, pp. 411- 416 ,(1989) , 10.1016/0091-6749(89)90127-9
William W. Storms, Stephen F. Bodman, Robert A. Nathan, Paul Chervinsky, Charles H. Banov, Robert J. Dockhorn, Irene Jarmoszuk, Howard J. Zeitz, Stephen J. McGeady, Jacob L. Pinnas, Saul Greenstein, SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis The Journal of Allergy and Clinical Immunology. ,vol. 83, pp. 1083- 1090 ,(1989) , 10.1016/0091-6749(89)90450-8
Harold M. Friedman, Loratadine: A Potent, Nonsedating, and Long-Acting H1 Antagonist: American Journal of Rhinology. ,vol. 1, pp. 95- 99 ,(1987) , 10.2500/105065887781693321
Peter J. Mauser, William Kreutner, Robert W. Egan, Richard W. Chapman, Selective inhibition of peripheral histamine responses by loratadine and terfenadine European Journal of Pharmacology. ,vol. 182, pp. 125- 129 ,(1990) , 10.1016/0014-2999(90)90500-6
Stephen P. Clissold, Eugene M. Sorkin, Karen L. Goa, Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. ,vol. 37, pp. 42- 57 ,(1989) , 10.2165/00003495-198937010-00003
R. M. Neves-Pinto, G. Moreira Lima, R. da Mota Teixeira, A Double-Blind Study of the Effects of Loratadine versus Placebo on the Performance of Pilots: American Journal of Rhinology. ,vol. 6, pp. 23- 28 ,(1992) , 10.2500/105065892781976718
W LONG, R TAYLOR, C WAGNER, D LEAVENGOOD, H NELSON, Skin test suppression by antihistamines and the development of subsensitivity The Journal of Allergy and Clinical Immunology. ,vol. 76, pp. 113- 117 ,(1985) , 10.1016/0091-6749(85)90813-9
W. Kreutner, R. W. Chapman, A. Gulbenkian, M. I. Siegel, Antiallergic activity of loratadine, a non-sedating antihistamine. Allergy. ,vol. 42, pp. 57- 63 ,(1987) , 10.1111/J.1398-9995.1987.TB02188.X